A study to assess the effect of AZD5055 on the pharmacokinetics (PK) of Nintedanib in healthy subjects.

Trial Identifier: D8960C00003
Sponsor: AstraZeneca
NCTID:: NCT05644600
Start Date: May 2023
Primary Completion Date: September 2023
Study Completion Date: September 2023
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
GB Glendale, GB, 91206